BioLife Solutions Inc
NASDAQ:BLFS
BioLife Solutions Inc
NASDAQ:BLFS
Price:
19.96 USD
10.83%
Updated:
May 10, 2024
P/B
Price to Book Value
Price to Book Value
2.7
Current
2.4
Median
2.3
Industry
Higher
than median
Higher
than industry value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
P/B
=2.7
Market Cap
/
901.5m
Book Value of Equity
337.7m
All Countries
| Market Cap | P/B | ||||
|---|---|---|---|---|---|
| US |
|
BioLife Solutions Inc
NASDAQ:BLFS
|
901.5m USD | 2.7 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.3T JPY | 7.2 | |
| CH |
|
Alcon AG
SIX:ALC
|
36.1B CHF | 1.9 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
190B DKK | 12.6 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
20.5B USD | 5.4 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
18.9B USD | 2.5 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
13.1T KRW | 25 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
61.2B CNY | 8.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.4B GBP | 4 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 1.8 | |
| CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.4B USD | 0.8 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/B
N/A
2-Years Forward
P/B
N/A
3-Years Forward
P/B
N/A
You don't have any saved screeners yet
